INTS3 and Miller-Dieker lissencephaly syndrome: It is unclear if 17p13.3 deletion predisposes cells to cancer though isolated cases of malignancy has been reported in patients of Miller-Dieker syndrome and it is therefore possible that loss of RPA checkpoint function is compensated by hSSB1/2-INTS3 pathway (56).